Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia
- DOI
- 10.1182/bloodadvances.2024014855
- Published
- 2025-11-12
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2024014855,
title = {Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia},
author = {Jong Wook Lee and Jun Ho Jang and Hirohito Yamazaki and Masashi Sawa and Masahiro Kizaki and Yoshiaki Tomiyama and Koji Nagafuji and Kensuke Usuki and Jyh-Pyng Gau and Yasuyoshi Morita and Jih-Luh Tang and Hung Chang and Masayoshi Noshiro and Akira Matsuda and Keiya Ozawa and Kinuko Mitani and Yoshinobu Kanda and Shinji Nakao},
year = {2025},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2024014855},
url = {https://doi.org/10.1182/bloodadvances.2024014855}
}RIS
TY - JOUR TI - Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia AU - Jong Wook Lee AU - Jun Ho Jang AU - Hirohito Yamazaki AU - Masashi Sawa AU - Masahiro Kizaki AU - Yoshiaki Tomiyama AU - Koji Nagafuji AU - Kensuke Usuki AU - Jyh-Pyng Gau AU - Yasuyoshi Morita AU - Jih-Luh Tang AU - Hung Chang AU - Masayoshi Noshiro AU - Akira Matsuda AU - Keiya Ozawa AU - Kinuko Mitani AU - Yoshinobu Kanda AU - Shinji Nakao PY - 2025 JO - Blood Advances DO - 10.1182/bloodadvances.2024014855 UR - https://doi.org/10.1182/bloodadvances.2024014855 ER -
APA
Lee, J. W., Jang, J. H., Yamazaki, H., Sawa, M., Kizaki, M., Tomiyama, Y., Nagafuji, K., Usuki, K., Gau, J., Morita, Y., Tang, J., Chang, H., Noshiro, M., Matsuda, A., Ozawa, K., Mitani, K., Kanda, Y., & Nakao, S. (2025). Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia. Blood Advances. https://doi.org/10.1182/bloodadvances.2024014855
Source records
- crossref · retrieved 2026-09-27T14:17:53.866Z